Botta C, Rizzuto A, Speciale M, Gigliotta E, Corsale AM, Romano F, Mussotto I, Aquilina C, Romano A, Biondo M, Tofacchi E, Di Simone M, Sciortino M, Brucato F, Guercio G, Di Caro M, Merenda A, Vasta S, Scazzone C, Bivona G, Calò V, La Manna MP, Caccamo N, Dieli F, Siragusa S, Meraviglia S. Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experience. Haematologica; https://doi.org/10.3324/haematol.2026.300864 [Early view].